Cargando…
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
BACKGROUND: SARS-CoV-2 seroepidemiological studies are used to guide public health decision making and to prepare for emerging infectious diseases. Disease occurrence estimates are limited in the Philippines, the country with the highest reported number of coronavirus disease-related deaths in the W...
Autores principales: | Malijan, Greco Mark B., Edwards, Tansy, Agrupis, Kristal An, Suzuki, Shuichi, Villanueva, Annavi Marie G., Sayo, Ana Ria, De Guzman, Ferdinand, Dimapilis, Alexis Q., Solante, Rontgene M., Telan, Elizabeth O., Umipig, Dorcas V., Ota, Kenji, Nishimura, Fumitaka, Yanagihara, Katsunori, Salazar, Mary Jane, Lopez, Edmundo B., Ariyoshi, Koya, Smith, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552163/ https://www.ncbi.nlm.nih.gov/pubmed/36221142 http://dx.doi.org/10.1186/s41182-022-00468-7 |
Ejemplares similares
-
Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines
por: Agrupis, Kristal An, et al.
Publicado: (2021) -
Correction to: Epidemiological and clinical characteristics of the first 500 confirmed COVID-19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines
por: Agrupis, Kristal An, et al.
Publicado: (2021) -
COVID-19 Screening for Healthcare Workers in a Tertiary Infectious Diseases Referral Hospital in Manila, the Philippines
por: Villanueva, Annavi Marie G., et al.
Publicado: (2020) -
Diphtheria in Metro Manila, the Philippines 2006–2017: A Clinical, Molecular, and Spatial Characterization
por: Saito, Nobuo, et al.
Publicado: (2020) -
COVID-19 screening on a tuberculosis ward in Manila, the Philippines
por: Sayo, Ana Ria, et al.
Publicado: (2020)